Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Publications: Haemophilus influenzae

2000 to Present:

top of page

1995-1999:

  • Centers for Disease Control and Prevention. Achievements in Public Health, 1900-1999 Impact of Vaccines Universally Recommended for Children - United States, 1990-1999. MMWR. 1999;48(12);243-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1999.
  • Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. The Haemophilus Influenzae Study Group. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. Am J Public Health. 1999;89:364-8.
  • Bisgard K, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229-37.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998.
  • Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae Type b Disease Among Infants and Children -- United States, 1987-1997. MMWR. 1998;47:993-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1997.
  • Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae type b disease among infants and children -- United States, 1987-1995. MMWR. 1996;45(42):901-6.
  • Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, and the H. Influenzae study group. Invasive Haemophilus influenzae serotype f disease: Clinical and epidemiological characteristics in the Hib vaccine era. Clin Inf Dis. 1996;22:1069-76.
  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae Type b disease among infants and children-United States, 1993-1994. MMWR. 1995;44(29):545-50.

top of page

1988 - 1994:

  • Centers for Disease Control and Prevention. Progress Toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993. MMWR. 1994;43(8):144-8.
  • Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
  • Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae Disease in Adults: Population-Based Surveillance. Ann Intern Med. 1992;116:806-12.
  • Farley MM, Stephens DS, Harvey RC, Sikes RK, Wenger JD, and the CDC Meningitis Surveillance Group. Incidence and Clinical Characteristics of Invasive Haemophilus influenzae in Adults. J Infect Dis. 1992;165:S42-3.
  • Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, et al. Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis. 1992;165 [Suppl. 1]:S34-5.
  • Wenger JD, Pierce R, Deaver KA, Plikaytis BD, Facklam RR, Broome CV, and the Haemophilus influenzae Vaccine Efficacy Study Group. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet. 1991;338:395-8.
  • Wenger JD, Harrison LH, Hightower A, Broome CV. Day care characteristics associated with Haemophilus influenzae disease. Am J Public Health. 1990;80:1455-8.
  • Harrison LH, Broome CV, Hightower AW. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Pediatrics. 1989;84:255-61.
  • Harrison LH, Broome CV, Hightower AW, Hoppe CC, Makintubee S, Sitze SL, et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA. 1988;260:1413-8.

top of page

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #